IHIrsa Hasan

Irsa Hasan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Irsa Hasan has a total of 41 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    GDMT Adherence and Arterial Grafting Strategy: Outcomes in GDMT-Compliant SIMA Versus GDMT-Noncompliant BIMA CABG

    by Kei Kobayashi, Xander Jacquemyn, Jianhui Zhu, Floyd W. Thoma, Derek Serna-Gallegos, David Kaczorowski, Johannes Bonatti, Francis Ferdinand, David West, Takuya Ogami, et al.

  • Open Access

    Surgical Versus Transcatheter Aortic Valve Replacement in Low-Flow, Low-Gradient Aortic Stenosis: Results From 1900 Patients

    by Xander Jacquemyn, Rohit Ganduboina, Michel Pompeu Sá, Irsa Hasan, Takuya Ogami, Derek Serna-Gallegos, Dustin Kliner, Catalin Toma, Amber Makani, Ibrahim Sultan

    Background: Low-flow, low-gradient (LFLG) aortic stenosis (AS) is associated with high-risk physiology and poor outcomes; however, the optimal intervention strategy, surgical aortic valve replacement (SAVR) versus transcatheter aortic valve replacement (TAVR), remains uncertain. Methods: A systematic review and pooled meta-analysis of studies reporting Kaplan-Meier outcomes after SAVR and TAVR in patients with LFLG AS, published through June 2025, was performed. Individual patient data were reconstructed from published curves. Analyses included Cox frailty models, restricted mean survival time (RMST), and two-stage meta-analyses. Adjusted analyses accounted for baseline differences, including age, comorbidities, and echocardiographic parameters. Results: Five studies comprising 1940 patients (721 SAVR and 1219 TAVR) were included. Patients undergoing TAVR were older and had higher rates of peripheral arterial disease, while other comorbidities and echocardiographic parameters were similar between groups. In unadjusted analyses, TAVR was associated with higher mortality compared with SAVR (hazard ratio (HR) 1.36, 95% confidence interval (CI) 1.11–1.65; p = 0.003). The estimated 5-year survival was 67% for SAVR versus 49% for TAVR, with an RMST of 0.64 years in favor of SAVR. Despite risk adjustment, TAVR was associated with higher mortality (HR 1.42, 95% CI 1.17–1.73), with a reduction in RMST of 1.06 years. Two-stage meta-analyses yielded consistent findings with low-to-moderate heterogeneity. Conclusion: SAVR was associated with significantly lower mortality in patients with LFLG AS than TAVR, both before and after risk adjustment. While these findings suggest a potential survival benefit, the data are observational and hypothesis-generating, and residual confounding cannot be excluded.

  • Association of GLP-1 inhibitors with cardiovascular outcomes in patients undergoing coronary artery bypass surgery

    by Irsa Hasan, Lily G. Bessette, Xander Jacquemyn, Yisi Wang, Kathir Subramaniam, Zain Hasan, Floyd Thoma, Takuya Ogami, Johannes Bonatti, David Kaczorowski, et al.


  • Open Access

    Impact of Age on Survival After Acute Type A Aortic Dissection Repair

    by Justin C. Wang, Xander Jacquemyn, Ibrahim Sultan, Derek Serna-Gallegos, Danial Ahmad, Johannes Bonatti, David Kaczorowski, Danny Chu, Takuya Ogami, Irsa Hasan


  • Open Access

    Arch-first approach in total arch reconstruction: The Pittsburgh experience

    by Irsa Hasan, Aryan Meknat, Derek Serna-Gallegos, Ibrahim Sultan

  • Open Access

    Factors Influencing Pain Scores and Opioid Demand after Robotically Assisted Cardiac Surgery

    by Irsa Hasan, Laura Seese, Rachel Deitz, Faaz Ashraf, Takuya Ogami, Kathirvel Subramaniam, Michael Boisen, Pyongsoo Yoon, David West, David Kaczorowski, et al.

    Objective. Introduction of minimally invasive cardiac surgery anticipated the reduction in postoperative pain but little quantitative data are available on this effect. This study investigated factors influencing pain scores and opioid demand after robotically assisted cardiac procedures. Methods. Using data derived from prospective robotic cardiac surgery and anesthesia databases, we analyzed 75 patients undergoing robotic cardiac surgery between July 2021 and December 2022. Study endpoints were mean cumulative pain scores measured on a 0–10 scale and opioid use on postoperative days (PODs) 1 to 4. Pain scores and oral morphine equivalent (OME) were correlated with perioperative variables. Results. Postoperatively, 39/75 (52%) of patients were extubated in the operating room (OR) and 34/75 (45.3%) were extubated within 24 hours of surgery. Mean pain scores declined from 5.8 (SD 1.5) on POD 1 to 3.8 (SD 1.6) on POD 4 and OME fell from 34.9 (SD 29) mg to 8.2 (SD 11.8) mg. OME use correlated significantly with pain scores (p < 0.01). Higher pain scores on postoperative day (POD) 1 were associated with diabetes (p = 0.006), tobacco use (p = 0.006), and extubation in the OR (p = 0.017). Opioid utilization was higher in younger patients (p < 0.001), heavier patients (p = 0.033), active tobacco users (p = 0.01), longer procedure times (p = 0.002), and those extubated in the OR (p < 0.001). Conclusion. Pain and opioid consumption after robotically assisted cardiac surgery are moderate but decline steadily within the first four postoperative days. Tobacco use and extubation in the OR were associated with increased pain and opioid consumption.

  • Open Access

    Association of Thoracic Aortic Aneurysm Versus Aortic Dissection on Outcomes After Thoracic Endovascular Aortic Repair

    by Irsa S. Hasan, James A. Brown, Derek Serna‐Gallegos, Edgar Aranda‐Michel, Sarah Yousef, Yisi Wang, Ibrahim Sultan

    Background: Because thoracic endovascular aortic repair (TEVAR) has become the standard of care for complicated type B aortic dissection (TBAD) and descending thoracic aortic (DTA) aneurysm, it is important to understand outcomes and use of TEVAR across thoracic aortic pathologies. Methods and Results: This was an observational study of patients with TBAD or DTA undergoing TEVAR from 2010 to 2018, using the Nationwide Readmissions Database. In‐hospital mortality, postoperative complications, admission costs, and 30‐ and 90‐day readmissions were compared between the groups. Mixed model logistic regression was used to identify variables associated with mortality. An estimated total of 12 824 patients underwent TEVAR nationally, of which 6043 had an indication of TBAD and 6781 of DTA. Patients with aneurysms were more likely to be older, women, have cardiovascular disease, and have chronic pulmonary disease compared with patients with TBAD. Weighted in‐hospital mortality was higher for TBAD (8% [1054/12 711] versus 3% [433/14 407], P P P P <0.001). Conclusions: After TEVAR, patients who presented with TBAD had higher rates of postoperative complications, in‐hospital mortality, and cost compared with DTA. The incidence of early readmission was substantial for patients undergoing TEVAR, faring worse for those undergoing TEVAR for TBAD as compared with DTA.